How is testosterone propionate dosed, and how many mL is a dose?

25 mg of Testosterone Propionate at 100 mg/mL is 0.25 mL, the 25 mark on a U-100 syringe.

Every vial at a glance. Pick a cell to draw it on the syringe.

Each row is a concentration; units are the dose over the concentration, times 100, on a U-100 syringe.
ConcentrationDraw per dose
100 mg/mL100 mg/mL: 10 mg is 0.1 mL, the 10 mark, 25 mg is 0.25 mL, the 25 mark, 50 mg is 0.5 mL, the 50 mark

An undated US drug handbook gives adults with male hypogonadism 10 to 25 mg of testosterone or testosterone propionate intramuscularly two or three times weekly.1

Strengths and mL per dose

25 mg of Testosterone Propionate at 100 mg/mL is 0.25 mL, the 25 mark on a U-100 syringe.

A US drug handbook lists testosterone propionate in oil as a 100 mg/mL injection.1 The two mixed-ester oils in the cited sources carry less propionate per mL: 30 mg in a 1 mL Sustanon 250 ampoule, and 25 mg (with 110 mg enanthate) per mL in the oil of a 2011 Indian study of 23 patients with hypospadias (Ahmad and colleagues).23 No cited source gives a syringe mark, so the table and the worked line divide the dose in mg by the oil's mg/mL: 25 mg from the handbook's 100 mg/mL oil is 0.25 mL, or 25 units on a U-100 syringe.1

What the handbook and the label give

No human-use US label for testosterone propionate turned up in DailyMed; the one US label found, Synovex H, is a veterinary implant marked not for use in humans.4 The undated US drug handbook gives boys with delayed puberty 25 to 50 mg of testosterone or testosterone propionate intramuscularly two or three times weekly for up to 4 to 6 months.1 For women with postpartum breast pain and engorgement it gives, for testosterone or testosterone propionate, 25 to 50 mg intramuscularly daily for 3 to 4 days.1 For women with inoperable breast cancer it gives 50 to 100 mg intramuscularly three times weekly.1

The UK Sustanon 250 label, for a four-ester product, gives testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests, and says that for adults (incl. elderly) one injection of 1 mL per 3 weeks is usually adequate.2 It adds that, in general, the dose is to be adjusted to the response of the individual patient.2 For female-to-male transsexual supportive therapy it says specialist centres have used 1 mL every two weeks to 1 mL every four weeks.2

What named trials used

No propionate-only dosing trial turned up: the first two rows are studies that followed testosterone levels after propionate injections (a single dose in Fujioka's study), and the other three gave propionate inside a mixed-ester oil.56738

TrialDose and schedulePeopleLength
Nieschlag 1976525 mg or 50 mg propionate, intramuscular, against 250 mg enanthateNormal and hypogonadal men (number not stated)Length not stated; testosterone above the lower physiological limit for 1 day after 25 mg, 2 days after 50 mg, 14 days after 250 mg enanthate
Fujioka 19866A single 25 mg intramuscular dose of deuterium-labelled propionateNormal men (number not stated)Labelled testosterone above the physiological level for 48 h
Chalapathi 2003, hypospadias7Testoviron oil (25 mg propionate, 110 mg enanthate) by weekly intramuscular injection in group B (dose not stated), against topical use at 2 mg/kg/wk in group A26 patients, 13 per group3 consecutive weeks
Ahmad 2011, hypospadias32 mg/kg body weight of an oil with 25 mg propionate and 110 mg enanthate per mL, deep intramuscular23 patientsGiven 4, 3 and 2 weeks before surgery
Büyükgebiz 1995, delayed puberty8200 mg testosterone as propionate, phenylpropionate and isocaproate, intramuscular, 4 times at 3-week intervalsThirteen boys, mean age 14.9 +/- 0.6 years2 years of follow-up

Route and storage

The Sustanon 250 label gives deep intramuscular injection, and says that, as with all oily solutions, Sustanon 250 must be injected strictly intramuscularly and very slowly.2 None of the sources cited here names an injection site, such as the buttock or thigh. The Sustanon 250 label, for a four-ester product, gives a shelf life of 5 years and says to store below 30°C, not to refrigerate or freeze, and to store in the original package to protect from light.2 The USP monograph for propionate injection asks for single-dose or multiple-dose containers, preferably Type I glass, and gives no temperature.9 Neither source states storage for propionate oil after opening or drawing up.

Frequently asked questions

How long does testosterone propionate last in the body?

A 2022 crystallography article on short testosterone esters gives, in its background, a half-life of 1 day for propionate, against 2.5 days for phenylpropionate.10 In Fujioka's 1986 study in normal men, labelled testosterone stayed above the physiological level for 48 h after a single 25 mg intramuscular dose, and in Nieschlag's 1976 study in normal and hypogonadal men, testosterone stayed above the lower physiological limit for 1 day after 25 mg and 2 days after 50 mg propionate, against 14 days after 250 mg enanthate.65

Does testosterone propionate need mixing?

No, the USP monograph describes it as a sterile solution in vegetable oil.9

What does the Sustanon 250 label say about women and children?

It says treatment may induce signs of virilisation in women.2 It also says safety and efficacy have not been adequately determined in children and adolescents.2

References

  1. GLOWM. testosterone. glowm.com
  2. electronic medicines compendium (UK). Sustanon 250, 250mg/ml solution for injection - Summary of Product Characteristics (SmPC) - (emc) | 5373. medicines.org.uk
  3. PubMed. Role of parenteral testosterone in hypospadias: A study from a teaching hospital in India. 2011. pubmed.ncbi.nlm.nih.gov
  4. DailyMed. Synovex H. 2023. dailymed.nlm.nih.gov
  5. PubMed. Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men. 1976. pubmed.ncbi.nlm.nih.gov
  6. PubMed. Pharmacokinetic properties of testosterone propionate in normal men. 1986. pubmed.ncbi.nlm.nih.gov
  7. PubMed. Testosterone therapy in microphallic hypospadias: topical or parenteral?. 2003. pubmed.ncbi.nlm.nih.gov
  8. PubMed. Treatment of constitutional delayed puberty with a combination of testosterone esters. 1995. pubmed.ncbi.nlm.nih.gov
  9. USP 32 (via drugfuture). Testosterone Propionate Injection. drugfuture.com
  10. PMC. Structural Aspects and Intermolecular Energy for Some Short Testosterone Esters. 2022. pmc.ncbi.nlm.nih.gov